《亞洲股市》深成及越南續升逾1%跑贏 印度及港泰股吐0.2%-0.7%
美股三大指數繼上周五續升1.3%-1.7%後,期貨個別發展,道指期貨高低見33,513/33,436,現報33,468,逆升8點;納指一百期貨最低見13,200,現報13,223,回吐0.6%;標普五百期貨低見4,122,現報4,126,回吐0.3%。亞太股市今天個別發展,美元兌日圓於亞洲升0.4%報133.37,日經高見28,258,收28,188,續升146點或0.5%。
深成四連升,最高見11,867,現報11,865,續升1.2%;滬指三連升,現報3,292,續升0.6%。越南(VNI)十連升,報1,077,續升1.2%。澳洲200六連升,最高見7,246,現報7,214,續升0.5%。新加坡海峽時報指數報3,279,續彈0.6%。吉隆坡綜指繼上周五回軟結束三連升後,今早回升0.5%報1,430。菲律賓(PSEI)繼上周五回吐2.2%結束三連彈後,今天高見6,524,現報6,511,微彈0.2%。印尼雅加達綜指終止兩連軟,最高見6,849,現報6,816,微彈不足0.2%。
區內餘下市場全部反覆受壓,泰國(SET)繼上周五回升後,今天反覆回軟,高低見1,613/1,593,現報1,598,吐0.7%。印度孟買繼上周五假後重開追升1.8%後,今天最高見59,204遇阻,掉頭曾低見58,842,現報58,882,倒跌0.2%。南韓(KOSPI)終止四連升,高低見2,485/2,467,現報2,470,倒跌0.3%。新西蘭50指數兩連吐,報11,838,跌0.4%。
港股終止四連升,恆指高低見20,475/20,226,現報20,275,反覆回吐125點或0.6%。藍籌藥業股表現較差,去年少賺近83%的中生製藥(01177.HK)挫7.5%曾低見3.97;藥明生物(02269.HK)及翰森(03692.HK)跌約4%及3%;阿里(09988.HK)、美團(03690.HK)、百度(09888.HK)、海底撈(06862.HK)及新奧能源(02688.HK)跌逾2.5%-5.5%。然而,受惠澳門3月賭收強勁的銀娛(00027.HK)及金沙(01928.HK)續漲逾半成。中芯(00981.HK)午後升幅擴至逾6%曾高見19.8元。油組及盟友國突然宣布減產,刺激油價曾急漲逾7.5%-8%,兩桶油中石油(00857.HK)及中海油(00883.HK)漲逾半成後,升幅收窄至約1.5%-2.5%。中移動(00941.HK)及九倉置業(01997.HK)漲近2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.